Philip Morris
An Estimate of Adult Mortality in the United States From Passive Smoking
Fields
- Author
- Wells, A.J.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Characteristic
- EXTR, EXTRA
- Site
- R529
- Named Organization
- US Natl Center for Health Statistics
- Author (Organization)
- Environment Intl
- Named Person
- Blot, W.J.
- Brownson, R.C.
- Buffler, P.
- Crofton, J.
- Dalager, N.A.
- Garfinkel, L.
- Geng
- Hirayama, T.
- Hunt, S.C.
- Koo, L.C.
- Lam
- Martin
- Pershagen, G.
- Repace, J.L.
- Reynolds, P.
- Robins, J.
- Samet, J.M.
- Sandler, D.P.
- Trichopoulos, D.
- Wilson, R.W.
- Wu, A.H.
- Brownson, R.C.
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512241-2244 Passive Smoking Affects Endothelium and Platelets
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- shc02a00
Document Images
(3)
En r.onmrnrlmrrnmronu!. Vol W pp _49-265. 198t;
Prunted'm the U.'SA. All nghts reserved.
AN ESTIMATE OF ADULT MORTALITY IN THE
UNITED STATES FROM PASSIVE SMOKING
A. JUdson Wells
102 Kdoonan~Glen: Wilmington Delaware 19807. USA
(Rrcrrvrd 9 December 1987; Aectpred 7 hPo 1988)
(I1tXr41211 IiR Si.fMl , ,tNl
Copyrtght c I90 Pergamon Press plc
r+OTIeE
This matanial may, be
prstacted by ca1700't
ttw (ritle 1711.5. Code3.
The purpose of this paper is to estimate the number of adult deaths per year in the United States
from
passive smoking. The epidemiological hteratureon passive smoking and adult mortality and'nncer and
heart morbidtt%, is reviewed. Combined relative risks for lung cancer. cancers other than, lung. and
heart disease are calculated for each sex and disease categon. These data along with estimates of
nonsmoker dcath rates and populations exposed allow calculation of annual deaths in each wtegory.
Red'ueed relative nsk and reduced exposure at older ages are taken into aceount as well as a
correction
for possible mtsclassihcauon of smokers as nonsmokers and exposed'nonsmokers as nonexposed Al-
together 415.000 deaths per year are calculated consisting of fung cancer (30(M1) other cancer
(11.000)
and'hean disease (32A00). Reasons why such high estimates for other cancer and heart disease may
be possible are explored. It is rnncluded'that exposure to environmental tobacco smoke can have
adverse long term health effects that are more senous than previously thought.
Introduction
Several attempts have been made to estimate U.S. adult
mortality from passive smoking. For example, Repace
and Lowrey (1985)'estimated the lung cancer deaths to
be about 5000~ per year. Fong (1982) estimated total
mortality at 10.000 to 50,000. Russell ernl. (1986) es-
timated total U.S. mortality at more than 4000. The
present estimate is based on epidemiological evidence
currently available on lung cancer, cancers other than
lung. and heart disease.
The Surgeon General of the United States (USSG.
1986) and the UIS. National Academy of Sciences
(NRC. 1986) have issued reports stating that passive
smoking can cause lung cancer. In the National Acad-
emy report the relative risks from the various lung can-
cer studies were combined into an overall relative risk
using a proced'ure somewhat similar to that which is
used in this work. The Academy report then projects
that about 20% of the 12,000 U.S. lung cancer deaths
per year among never smokers is due to passive smok-
ing. This is reasonably close to the 3000 per year pro-
jected here for never smokers plus exsmokers. The
methods used in the National Academy report are fur-
ther detailed ini Wald etal: (1986). Blot and Fraumeni
(1986) have also presented an overview of studies of
lung cancer and passive smoking. They use a method
of combining the relative risks from variousstudies es-
sentially identical to that used here. Thus, the proce-
dure of, combining relative risks from various passive
smoking studies to obtain overall relative risks and
tighter confidence intervals is now welli established by
authorities in the field. Also, the method used here to
calculate annual deaths from the relative risks appears
to be validated by the National Academy results for
lung cancer. However, both the Surgeon General's task
force and that of the National Academy felt that the
data, as of 1986, on cancers other than lung and on
heart disease were still too meager to allow calculation
ofireliable overall risks.
Since 1985 considerably new epidemiological infor-
mation has become available, particularly on heart dis-
ease. This new information is reviewed and combined
with the old data to calculate updated relative risks.
overall confidence limits, and estimated annual U.S.
deaths from passive smoking and the three main dis-
eases, namely, lung cancer, cancers other than lung.
an&ischemic heartidisease. The total particulate matter
dose retained by passive smokers is too low to account
for the health effects of passive smoking, if one starts
with the health effects exhibitedby direct smokers and
ratios down from the dose retained by them. Reasons
why such a discrepancy might occur are explored.
249

,1
250
Methods
Studies to be considered in the analyses were ob-
tained originally from the literature searches of the U.S.
Office on Smoking and Health (OSH', 1979-85). More
recently. studies have come to light primarily through~
personai! contact with workers in the passive smoking
field. Criteria for admitting data to the analysis are:
1. Studies on the association of passive smoking with
adult mortality or morbidity from lung cancer. other
cancer or ischemic heart disease were included. All
cause data were not used because essentially no male
data are available. The female data, if calculated,
yield overall results that are in the same range as
the results derived from the three main diseases (see
Appendix B)i Emphysema: is not included because
the nonsmoker death rate is so low that less than
I% of deaths from~ passive smoking would be pre-
dicted from this source (see Appendix B).
2. Retrospective studies should have controls.
3. Observations should be base& on spouse exposure
or on general exposure of more than 10! years du-
rationL The diseases under study are known to have
long induction ~ periods, and it is assumed that most
married people old enough to die of passive smoking
would have been exposed 20 years or more.
4. Enough data should be available from the study to~
allow calculation of a weighting factor~ for combining
the relative risks.
Two risk models were used' and a third was consid-
ered. The primary model used combined relative risks
from the various studies that pertaine&to a given sex
and'disease and assumed that the combined relative risk
was constant with age, although variation with age of
the underlying neversmoker deathi rate and'the fraction
of the population exposed were included. In the sec-
ondarv risk model the combined relative risk was also
allowed to vary with age. These models were suggested
in part by the considerations in James Robins' Appen-
dix D in the National Academy report (NRC. 1986).
The third risk model was based on the rate difference
between the death rates for exposed and nonexposed
populations. A detailed analysis of this model for heart
disease in women was carried out (see Appendix C). Itl
was concluded that the relative risk models were much
superior to the rate difference model when combining
data across different cultures as is the case here where
some of the studies are from the orient.
Wherever a study showed both a crude relative risk
or odds ratio and an adjusted ratio, the adjusted ratio
was used. To obtain a combined relative risk a method
similar to that ofl Blot and Fraumeni (1986) was used.
Case control studies were aggregated using Program 2
of Rothman and Boice (1982). Cohort studies were ag-
gregated using Program 7. A combined relative risk for
A J V.ells
the two aggregates was obtained using:
"',o In R« - w«, In R«
Rr6 = ezp
wCo t wrC
where R~,. Rro, and R«, are the relative risks for the
combined totall the cohort studies, an6the case control
studies, respectively, and wro and wK are the weights
for the cohort an& case control studies. respectively.
which are the inverse of the respective variances. Vari-
ance is taken as the square of the standard' deviation
which is equal to InA/x, so the weight. w=(X/ln R)=.
The source of, these equations is Rothman ( 1986) Con-
fidence intervals were calculated fromia combine& X =
w"=1n R, For some studies it was necessary to calculate
a chil from the confidence limits in order to calculate a
weight since no other data were available. These data
were then combined with the rest using Eq,. (1). Aees
of' death from 35 and up were used and should include
essentially all adult deaths from passive smokinQ. In
some studies morbidity relative risks were reported
whereas our interest is in mortalitv. The morbidity rek
ative risks were accepted as surrogates for: mortalitv
relative risks because, for cancer. the survivalirates for,
exposed and nonexposed cases appeared to be similar,
while, for heart disease, incidence relative risks, if anv
thing, are lower than mortality relative risks (Svendsen
et al.. 1987).
The 1985 smoking status for U.S. residents in 5 vear
age increments was obtained from the National Center
for Health Statistics. Nonsmokers were equated to
never smokers plus exsmokers. The fractions of never
smokers living with ever smokers (24~'r for males an&
60% for~ females), all of whom were considered to be
exposed~ were obtained from controls of the U.S. base&
studies for all three diseases. These fractions were as-
sumed to hold4lso for nonsmokers (never plus ex). The
fractions of all nonsmokers exposed as nonsmokers liv-
ing with nonsmokers, but still exposed at home or at
work (37% for males and 16% for females). were ob-
tainedfrom Friedman et al: (1983). These fractions were
assumed to hold for nonsmokers living with never smok-
ers. By adding the two fractions the total nonsmoker
exposure of 61% for males and 76% for females was
obtained. These overall exposure fractions are known
to be higher at younger ages and lower at older ages.
The data of Friedinan et al: (1983) were used to develop
smoothe& values of fraction exposed 10 years earlier
(midpoint of a 20 year exposure) for each sex and 5
year age interval normalized to 611% for males and 76c'c
for females. By multiplying each population element
by each fraction exposed element, the exposed popu-
lation by sex and 5 year age interval could be deten-
mined.
Death rates for never smokers for lung cancer by sex
and 5~year intervals were drawnifrom Garfinkel (1981)

i
Adult mortality trom passi%c smoking
an& smoothed using a semi-log plot against age. For
cancers other than lung for females a semi-log plot of
1984 age specific death rates for ages 35+ was devel-
oped for malignant neoplasms less malignant respira-
tory neoplasms from the data of the National Center
for Health Statistics (1986) Then. a parallel plot was
developed using as reference points the neversmoker
data of Hammond~ (1966) for ages 45-64 and 65-79 to
yield neversmoker rates for a¢es 35 + for each 5 year
age interval'. For heart disease never smoker death rates
by sex and 5 year age intervals for 1963 were developed
from the appendix tables in Hammond (1966). These
were reduced to 1984 equivalent rates (with the reduc-
tiom factors corrected for the effects of smoking) by a
technique similar to that used by the U.S. Office of
Technology Assessment (OTA. 1985). Semi-log graphs
were used to estimate never smoker death rates by 5
year age intervals for the entire age range (see Appen-
dix A. Table A3).
The excess death rate for never smokers for passive
smoking (Dp,) for each sex. disease and 5 year age range
was calculated from the never smoker death rates (D.)
using the formula:
D: . = Dti,(R - 1)l(F,,(R - 1)+ 1): (2)1
where FD is the fraction of the population that is ezpose&
and R is the combined relative risk. This excess death~
rate was assumed to apply to all nonsmokers. Deaths
were then calculated bymultiplying the passive smoking
excess death~ rate by the exposed population for each
sex and 5 year age interval, and summed. For those
calculations where the relative risk was assumed to have
varied with age. the excess death rates for passive smok-
ing were recalculated from the age specific relative risks
for each 5 year age interval. Additional calculations
were carried out to show the effects of bias including
those from misclassification of smokers as nonsmokers
and exposed nonsmokers as unexposed. using a method
similar to that of Wald~er al. (1986) L
Results
Relarrve risks
The results for passive smoking relative risk for fe-
males for lung cancer are shown in Table 1. The three
cohort studies are listed first an6show a combined rel-
ative risk for all exposures including exposures to
exsmokers of 1.34. At the time the analysis was made
there were fourteen acceptabie case control studies with
a combined relative risk of 1.50. The overall combined
relative risk, based on 1,174 cases, is 1.44 with 95%
confidence limits of 1.3-I.7. The male lung cancer ob-
served relative risks are shown in Table 2. There are
now nine studies with 144 total cases. The overall com-
bined relative risk is 2.1 with~95% confidence limits of
=51
1.3-3.2. Data excluded from Tables I an&2 along with~
the reasons were the following: Chan er al. (1979). cur-
rent exposure onfy; Knoth et al. (1983). no controls;
Kabat and Wynder (1984)' nonspouse data. current ex-
posure only; Buffler er al: (1984)~ 0-32 year data. not
a: minimumi of 10'vears exposure. A paper ba Dalager
et al. (1986) d'escribes a pooling of' data from Correa er
al. (1983), Buffler er al: (1984) and a stud~ of males in
New Jersey. They observed an adjusted odds ratio for
spouse exposure of 1.47, but since Correa er al: (11983).
and Buffler, er a!. (1984). were already included iniTa-
bles 1 and 2 and' since the New Jersev data were not
available separately, it was decided to omit the Dalager
er al. (1986) study from this analysis. AI'so. available
were abstracts of two recent papers. Gene er al. (1987)
from China with a relative risk of 2.2 and Inoue and
Hirayama (1987) from Japan with a relative risk of =.3..
both for females. Also NV K. Lam (1985)~ in a thesis
from the University of Hong Kong that is quoted in
Lam et al. (1987) found a relative risk of 2.0 for ad-
enocarcinoma among females. These inputs arrived too
late to be included in the analysis.
The data ofHlravama (1984a) on femalp lung cancer
are sufficiently detailed to indicate a declining relative
risk with age from 1.87 at approximately age 501to 1.433
at approximately age 75. These data were used'to de-
velop a second death caltulation assuming a declining
relative risk. but still! normalized to 1.44. However,
Hirayama's data show no such decline in passive smok-
ing relative risk with age for, males. Instead, the trend
appears to rise with age. so no secondary calculation
was made.
There are now five studies relating passive smoking
to total cancer or cancer, other than lune in females.
The individual and combined relative risks for females
are shown in Tablt 3. The total combined relative risk
is 1.16. The total cases. 2.933, are two and one-half
times the total cases for female lung cancer (Table 1)
although 2.505 are concentrated in the large Hirayama
(1984a) study. This is a large data base. The total com-
bined chi square is 11 compared to 27 for female lung
cancer.
The two largest of the female studies. Hirayama
(1984a) and Sandier et a!. (1985): cover different age
of death ranges. Hirayama covers 50 to 80 t while
Sandler er al: cover <30 to 59. The two studies taken
together would indicate a rather sharp decline in rela-
tive risk with age fromiabout 3.5 at age 40 to about 1.04'
at age 80: The high relative risks at the younger ages
may be due to premenopausal breast cancer (see San-
dler er al., 1986). Two calculations of Ui.S. female
deaths from passive smoking and other cancers were
made, one using the 1.16 relative risk from Table 3 at
all ages and one using the declining rela;ive risks.
Gillis et al, (1984). Sandler era1. (1985). and Rey-
nolds (private communication) also report on other can

252
Table 1. Female relative risks for, lung cancer from, passive smoking: A. l i We I I s
Hichest All Msntel!
Exposure Exposures Trend~
T
l
Locale ota
Cases RR 2-tail p RR 95 c7c C.L. I-tail p
Cohort Studiesr
Hlrayama (1984a)
Japan
200
1.9
0.002
1.6
1.1-2.2
0.002
Garfinkel (1981) , l.'nited~States 153 1.2 0.8-11.6 -
Gillls er a1. (1984) Scotland 8 - - 1.1 0;.-5.6
Combined Cohort 361 1.34 1.1-1.7
Case Control Studies:
Trichopoulos et a!: (1983)
Greece
77
2.6
0.19
2.1
1.2-3.6
0.ot15,
Cortea enal. (1983) Louisiana 22' 3.5 0.02 2.1 0.8-5.2
Buffler er a!. (1984)'. Texas 27' - - 0.9 0.4-2.3
Kabat and Wynder (1984) United States 24 0.8 0.3-2.5
Sandier er a6 (1985) Nbrth Carolina 2 - - inf -
Garfinkel et a1. (1995) United States 11& 2.0 0.05 1.3 0.8-1.9 UA25
Wu eral. (1985'). California 28" - - 1.2 0.5-3'.3
Lee et at: (1986) lJntted Kinedom 32 - - 1.0 0.4-17,
Akiba et a!: (1986) Japan 94 ::l - 1.5 0.9-_:6 T06
Koo et al. (1987) Hbng Kong 86 1.2 - 1.6 0.9-3:1
Pershagen et al. (1987) Sweden 67. 3,2 - 1.2 0.7-2.1 012
Humble er a!: (1987). 1New Mexico 20 1.2 - 2.3 09-6:6
Btownson~eraP (1987) Colorado 19 - - 1.7 0 4-3A.
Lam et al.' (1987) Hong Kong 199 - - 1.65 1.2-'_-4
Combined Case Control 813 1.50 1.3-1.8
Combined Cohort and C/C 117.3 1.44 11'6-1.66
' Private communication.
"From Blot and Fraumeni (1986).
cer in males. The relative risks were 0.6, 1.5 and near
unity., respectively. The number of cases.in each study
is very small~withino statistical significance. Therefore,
it was decided to use a neutral relative risk of 1.0 for
males for cancer other than lung until more data become
available.
There are now six studies of passive smoking and
heart disease in females. The individual and combined
relative risks are shown in Table 4. Studies new, since
1985 are Lee etal: (,1986), Martin era1:,(,1986a).and the
important, large Helsing et al. (1988)paper from Mary-
land. The overallicombinedrelative risk based~on 1.622
cases is 1.23 with 95% confidence limits of 1.11 to 1.36
and a combined chi square of 16. Helsin&er al. (1988)
and Martin et al: (1986a) provide data for younger
women and indicate high relative risks (average 2.45)
Table 2. Male relative risks for.lung cancer from passive smoking.
Highest Alli Mantel
Exposure Exposures Trend
Locale Total
Eases
RR 2-tail p
RR
95 % C.L. 1-tad p
Cohort. Studies
Hirayama (1984a)
Japan
64
2:3 0.16
2.25
1.11- 4.9 0.021
Gillis et al.. (1984) Scotland 6 - - 3.3 0.7 -16.5
Combined Cohort 70 2.5 1.2 - 5.0
Case Control ~ Studies: ,
Correa n ar. (;1983)'!
Louisiana
8
- -
2.0
0.4I -10 - ~
Buffler er al: (1984) , TTexas 8' - - 1!.6 0:3' - 811 - O
Kabat and Wynder (1984) United States 12 - - 1.0 0:3 - 3:2' - N
Lee er ar. (1986), United Kingdom, 15 - - 11.3 0:4 - 4.6 -
Akiba et al. (1986)
Japan
19
- -
1.8 ~
0i5 - 5.6 -
Humble et al. (1987)' New Mexico 8' - - 4.2 1.0 -16,8' - ~
Brownson er al. (1987)± Colorado 4 2.7 0.2 -31
Combined Case ControV 74 1.8 1.0 - 3.3
Combined Cohort and'C1C 144 2.1, 1.3 - 3.2 ~
'Private Communication. ~

Adult mortaltta (romipassi~e smoking =53
T'able3. Femalt relative nsks for cancer other than lung from passive smoktng.
Highest, All Mantel
Exposure Exposures Trend
T
l
Locale ota
Cases RR 2-tail p RR 95 % C.L. I-tail'p
Cohort Studies:
Hiracama (1984aY
Japan
2505
1.16
0.01
1.11
1.0 -1.2
0!05
Gillis el al. (1984) Scotland 43 1.2 0~6 -2:5
Reynolds er'al: (1987) Callfornia 70, 1.7 1.1 -2.7
Combined'Cohort 2618 1.13 1 03-1.?4
Case Control Studies:
Miller (1984)=
Pennsylvania
84'
1.25
0.7 -:?
Sandier et ad: (1985) Nonh Carofina 231 2.0 1.3 - 2.9'
Combined Case Control 315 1.7 1', -2 45
Combined Cohort and 2933' 1.16 11.06-1..7
CC
I
'Obtained'by subtractin@ data for lung cancer from data for all sites.
'Pro.-ided bv Dr. Revnolds.
A¢e adjusted Mantel+Haenszel values for nonemployed wives.
for ages up to abouv5Q. At higher ages there is no trend
with an average relative risk of 1!.17 holding out to
age 84.
For male heart disease and passive smoking there
are now four studies (see Table 4). The two new ones
are Lee er al. ('1986) and'Helsing et a!: (1988). The resulti
of Svendsen er al. (1987) is shown for information, but
is not, used in calculating the combined relative risk
because it pertains to a high risk group. The combined'
relative risk based on 443 cases is 1.31 with 95% con-
fidence limits of 1.1 to 1.6 and a combined chi square
of, 9.The results are remarkably uniform. As in the
female data the relative risk is highi at the younger
ages, about 2.9, but declines to a nontrend average ofi
1.28 which extends from age 55 out to the older ages..
Svendsen et al: (1987)! show than there was very little
difference between never smoking men married to
nonsmokers andIhose married to smokers in the major
coronary risk factors such as baseline blood pressure..
total: cholesterol, and LDL cholesterolL Thiswork was
reported in more detail in, Martin et al: (1986b). Smalli
differences were found in weighr (195 vs. 190 if wivess
were smokers) and drinks per week (10 vs. 8 if wives
were smokers). On the other hand. Garland etal. (11985)
Table 4. Relative risks for heart disease from passive smoking
Highest
Exposure All
Exposures Mantel
Trend
Localt Total
Cases
RR
2-tail p
RR
95 ri C:L.
1-tail p
Females
Cohort Studies<
Hira}ama (1984b)
Japan
494
1
3
0.038
1.16
0.9- 1.4
0.0:
Gdlis er d. (198Y), Scotland 21 - 3:6 U.9-13.8
Garland eraL (1985), California 19 3:5 0.9-13.6
Helsmg eral: (1988) , Maryland 988 1.27 1.24 1'.1- 1.4 0.005.
Combined Cohort 1522 1.23 G.1- I.4
1I Case Contro1 Studies:
Lee er al: (1986) United Kingdom 77 0:9' 0 7- 1!.3
Martimeral: (1986a) Utah 23 2.6 1.2- 5.7
Combined Case Control 100 1.29 0.8- 2.U
Combined'{ohort and CrC 1622 1.23 1.1- 1.4
1 Males
Cohort Studies:
Gilliseral.(1984)i Scotland 32 1.30 0.7- 2.6
Lee er al.' (1986) United Kingdom 41 L24 0:5- 2.6
Helsing et a!.' (1988) Maryland 370 1_31 1 1- 1.6
Combined Cohort 443 1.31' 1_1- 1.6
Svendseneral: (1987)' United'States 13 2.2 0:7- 6.9
'Based on Cochran chi-square of 9.2.
'MRFIT cohort of high risk individuals. included for information only.

A. J Wells
J
found that never smoking women married to smokers
had slightly lower weight. slightly lower bioodpressure,
and slightly higher cholesterol, all nonsignificantlv dif-
ferent, versus never smoking women married to never
smokers. All of' these authors conclude that the in-
creased passive smoking risks they observed cannot be
ascribed to differences in the major coronary risk fac-
tors between passively exposed and nonexposed never
smokers.
It is impressive that the relative risks for heart disease
from passive smoking rise in an orderly manner from
the lowest risk group. Japanesewomen at 11.16. through
American worrten at 1.27, and American men at 1.31,
to highi risk American men at 2.2.
A correction for misclassification was attempted for
all, three disease categories. Following Wald et aG.
(1986)', and presuming that the passive smoking studies
were done somewhat more carefully than the general
questionnaire studies thevcite, it was assumed'that 5%
of ever smokers were misclassified', as never smokers.
Along with Wald et al' (1986) we assumed that the
nonexposed nonsmokers were actually exposed to 1/3
the extent of the exposed nonsmokers except that for
Greece. Japan, and Hong Kong, where less than 30%
of women had ever smoked, the correction for nonex-
posed female nonsmokers was omitted. It is believed
that older. nonsmoking women in Greece and Japan.
and~probably in Hong Kong also, because of their social
habits, were exposed to relatively little tobacco smoke
beyond that of their husband's. Since most of the mis-
classified smokers were found to be light smokers or
longstanding exsmokers, reduced relative risks for the
misclassified ever smokers were calculatedas noted in
Appendix A. The modified passive smoking relative
risks are shown in Table 5. The false relative risks due
to smoker misclassification are somewhat lower than
calculated earlier by Wells (1986) because of the as-
sumption of light smokers and long, term exsmokers
among those misclassified', following Wald et al. (1986)'
and the use of a more accurate formula. lnigeneral. the
misclassification of smokers has a large negative effect
on male relative risk which is more or less offset by the
positive effect of exposure of the "nonexposed! "' For
females the smoker misclassification effect is small to
negligible, burbecause the relative risks are smaller and
no correction was made to '"eastern"' data (lapan,
Greece, and' Hong Kong)L the positive effects of ex-
posure of "nonexposed" are also smaller.
Calculation of Deaths
The details for the calculation of' female lung cancer
deaths from the relative risks. both constant and de-
clining, are shown in Table 6 as an example. Similar
calculations were made for the other disease and sex
categories and are shown in Appendix A. The results
of all of the calculations are summarized in~ Table 7.
These results are restated per million total population
in Table 8. Where the relative risk appears to decline
with age and where neversmoker death rates at the
younger ages are low, as in female heart~ disease and
lung cancer, there is a reduction in mortality calculated'
by'using the age specific relative risks. Otherwi'se, the
higher exposed population at the younger ages out.
weighs the higher death rate at older ages and total
mortality is increased. In terms of' total deaths the ef-
fects of using age specific relative risks tend to cancel
out. The totaL deaths, before adjustment, for misclas-
sification. for both males and females are about 19.500
for a totalI for both sexes of about 39.000.
The effects of misclassification on total deaths are
substantial, raising the total to 53,000. Most of' this
increase is in heart disease where the numbers are large
and the effects of smoker misclassification, although not
necessarily small, are still heavily outweighed by the
partial exposure of the "nonexposed."
To be conservative a best estimate for passive smok-
Table 5. Passive smoking relative risks modified'For misclassification.
Lung Cancer Other Cancer Heart Disease
Females
1. Combined relative risk.
1.44
l.la
1.23
2. False rttative risk due to projected 5%
smoker misclassification.
E011
1. t102
1.01
3. Combined relative nsk corrected for
smoken eusclassification, (1) + (2):
1.43
1.16
1.22
I I
4. (3) corteaed'for exposure of"'non- ~
exposed" at 113 that of exposed dg'
I 1121 1.32 ©
.
Males
1. Combined relative risk.
2'. False relative nsk due to projected 5% .
2.1
1.0'
111
GrJ~
1~1 I
l
smoker misclassificanon. 1.3 - 1.19 f
3: Combined relative risk corrected'for
smoker misclassification. (1) * (2),
11.6
-
1.17
4. (3) corrected for exposure of "non-
exposed" at 1/3 that of exposed.
2 4
-
1.29
~
~
..~
Assumed value tor lack of better data.

Adult mortaun, from passive smoking 25s.
Tablt 6 Annual U. S. female lung cancer deaths from passive smoking,
Relative Risk Relative
Constant at 1 4-0 Risk
Neversmoker No
k E
d D
l
A
f
h R nsmo
er xpose ec
ining
ge o
Death Deat
ate
per 100.000 Population
1000's Fraction
Exposed Population
1000's Excess
Death Rate Deaths
RR
Deaths
35-39 1.6 6150 0,94 5781 0.50 29 1.70 39
4U-44 2.4 462? 0;92 425? 0.75 32 11.69 43
45-49 3.6 3836 0:89 3423 1.14' 39 11.68 5_
SO-54 5.3 3856 0;87 3355 1.69 57 1.62 72
55-59 7.8 4161 0!84 3495 2.51 88' 1.56 104
60-64 M0 4192 0.77 3228 3.62' 117 1.J9 126
6_5--69 16.6 4160 0.70~ 2912 5.55 162 1.43 159
70-74 23.5 3447 0.59 2030 8.21 167 1.36 142
75-79 34 3004 0.49 147'_ 12.3 181 1.'_9 1_7
80-84 46 1886 0.29 547 18.0 98 1.IR 43
B5- 52 1'003 0.10 100 21.9 2-1 1.09 4
Totals 13.0 40291 0 76 30595 3.0 992 911
ing deaths might be 46.000. half'wa. between the 39.000
calculated directly from the relative risks and the 53,000
calculated using the modified relative risks. By disease
the total would consist of 3.000 lung cancer. 1'1.000
other cancer. and 32.000 heart disease. For each million
of total population the deaths by disease would be 13
for lung cancer, 46 for other cancers, and 134! fon heart
disease. These numbers may be useful for populations
similar to that of the United States imterms of~ propor-
tions of' never smokers. exsmokers, and~ smokers. and
in terms of the proportion of'the population tha is less
than 35 relative to that over 35. For other populations
the permillion numbersare best not used, but the meth-
odology can be used. That cancer other than lung and
heart disease are legitimate contributors to deaths from
passive smoking is supported in Hi'rayama. (1984a.b))
in, his large prospective study. He found significantly
elevated risks for all three diseases, and his result, for
lun¢ cancer is now believed to be valid, (USSG 1986;
NRC, 1986). It'is difficult to:believe that his lung cancer
result is valid while the other two are not,.,
Discussion
The cancer sites for passive smoking appear to differ
somewhat from those for, direct smoking. Using infor-
mationion specific cancer sites from Dri. Hiravama (pri-
vate communieation) it appears than cancers common
to both types of smoking are lung. liver, cervix, nasal
sinus, and leukemia. Some of these cancers are only
weakly associated with, direct smoking.. Cancers asso-
ciated to some de¢ree with, direct smokine. but absent
in passive smoking are buccal cavity. pharynx. larvnx,
esophagus, stomach (Hirayama, 1984a),. urinary blad«
der (Kabat ec al:, 1986). kidney and pancreas. Cancers
related to passive smoking, but absent in direct smoking
are brain (Hirayama. 1984a), endocrine glands (Sandler
era1., 1985). lvmphoma and breast (:Sandler et al., 1985.
1986( Hirayama. private communication) The first
three are significant at the 95% level. The combined
breast relative risk of 1.4 ', is significann at on1N 881~%r.
Higher relative risks for these four sites might be found
for direct smoking if epidemiologists used~ nonpassivel~
Table 7, Summary: IJ.S. annua/'deaths from passive smoking
I
I
Females:
1. Constant combined relative risk.
2. Relative risk declining with,age.
3. (l,) corrected for misclassificauon.
Males:
1. Constant combined relative nsk.
2. Relative risk declining with age.
3. (1,) corrected for misclassificatton.
Totals for both sexes:
1. Constant combined relative nsk.
2. Relative risk declining with age.
3. (1) corrected for misclassification.
Best cvrrent estimate. both sexes (rounded).
Lung Other Heart
Cancer Cancer Disease Total
992 8599 9769 19359
911 11165 7602 1967R
1232 12-180 14995 28507
1606 0 17335 18931
1606 0 18164 19770
2499 0 2..467' 24966
2598 8509 27103 3R?(Nt
2517 11165 25764, 39-t.SR
3731 12280 37462 53473
30W 71000 32000 46000

256
T!able 8. Summarv: Deaths per million population in U.S. from passive smoking.
(based on 239.000.000 U.S. poputt+tion in 1985)
.
Lune
Cancer Other
Cancer Hean
Disease
Total
FFemales:
1. Constant combined'relative ruk. J'.15 35.98 40.87 81.00
2. Relative nsk declinin¢ with~atae. 3;81 46,71 31.81 8?.33
3. (1J corrected for, mtsclassdicatton. 5,15 51.38 62.74 1119,27'
Males:
l. Constant combined relative risk.
6,72
0
7_:=3
79::5
2. Relative nsk declining with age. 6,i2 0 76.00 8'_:7_
3. (l) corrected for misdassiGcauon. 1046 0 94.00 104.46
Totals for both.sexes:
1. Constant combined relative risk.
10.87
35.98
113:a0
I60':25
2. Reltrtive nsk declining with age. 10.53 .i6.71i 107.81 165 05
3. (1),corrected for misctassificanon. 15.61 51'.38 156:7.3 223.73
Best current esttmate, both sexes (rounded). 13 46 134 193
exposed never smokers as the referrent category rather
than all' never smokers as is usually done. Another dif-
ference betweenipassive smoking and direct smokinrt is
that the ratio of lun¢ cancer deaths to deaths from other
cancer for females or from heart disease for both sexes.
is much lower in passive smoking than in direct smok-
ing.
These differences irt, mortality effects are probablyy
real and' reflect differences in chemistry' and physics
between direct, smoking and passive smoking. Environ-
mental tobacco smoke is generated~ in the burning tip
of the cigarette at a lower temperature than, direct
smoke and therefore contains higher proportions of,
complicated organic compounds that; tend to be carcin-
ogenic (Brunnemann cr al:, 1978). More imponantly,
(see Appendix D)' the mainstream smoke, although~
generated at a particle size of about, 0.7 µm, is very
concentrated and appears to agglomerate into larger
particles. Deposition rates are hieh, about, 80%. De-
position occurs primarily in the mouth or in the larger
airways of the lung where the particles are cleared rel-
ativeiiy quickly into the mouth. This material is then
swallowed.Some of it may be eliminated and produce
no health effects at all or it may cause the digestive
type cancers observed. Only a portion of mainstream
smoke appears to remain as small particles that can
penetrate deeply' into the alveolar region. Environ-
mental tobacco smoke, on the other hand', is very d'ilute,
with~a mass median diameter of about 0.41µm. Particles
in this size range have very low deposition rates, on the
order of~ 10%, but: what does deposit does so deep im
the aNveolar region of the lung where clearance times
are longer.. Black and Pritchard (1984) estimate that
ci¢arette tar has a 117 hour half-time rate of clearance
from the alveolar region, much longer than clearance
times frome the ciliated parts of the lung. but much
shorter than for inert particles. This means that smoke
particles are very likely dissolving in the fluids in the
alveolar region, and are being cleared into the blood
and lymph systems for circulation throughout the body:
In summary, there are two types of smoking: (a))
large particle smoking. or its equivalent, which is the
major component of direct smoking. which resuits in
massive deposition in the mouth, and larger airways of
the lung, rapid clearance, cancers of the mouth. central
lung and digestive system. and possibl v heart disease.
and (b) small particle smoking. which is a minor com-
ponent of direct smoking, but the entirety of passive
smoking. and which results in low doses deep in the
lung. slow clearance, some lung cancer, but primarily
other cancers and' adverse heart effects.
These differences in chemistry and physics also ex-
plain, at leastin part-the rather high monality observed
for passive smoking relative to the deposited dose of
particulate. Smoke retention by a passive smoker is only
about 1/400 that retained by a direct smoker m a 16
hour day (0.64 mg for the passive smoker per C;SSG
(1986, p: 196) and 2-t0 mg for the direct smoker assum-
ing twenty 15 mg tar cigarettes and 80cic retention). In
comparison, the ratio of lung cancer death rates is about
1/35. For cancers other tham lung in females the ratio
is about 1/7, for heani disease in females about 1. 141
and for heart disease in males about 1/3. Preliminarv
calculations which are showtn in Appendix D indicate
that the smoke retained deep in the alveolar region may
have a dose ratio higher than 1/-100, perhaps as high as
1/60: It may be that' carcinogenic matenali that bollu-
bilizes and clears from the alveoli into the blood may
cause not only some of the cancers other than lung that
are observed in passive smoking, but also some of the
heart disease from passive as well as direct smoking.
The hypothesis of Benditt and: Benditt (1973) that ar-
terial'. plaques are caused by, DNA-modifying agents is
receiving increasing support. See, for example. the re-
cent work of Penn er al: (1986)~ on cell transforming
capability of human atherosclerotic plaque DNA and
the earlier work of Albert u al. (1977) an& Penn eral:
(1981) on the formation of arterial plaques in cockerels
with dimethylbenz(',n)anthracene and benzo(a)pvrene.
Another possible factor that, might help explain the
disparate mortality effects versus dose isthe le%ell of
disease susceptability in passive smokers versus direcn

Adult mortality from passive smoking
smokers. The median age for passive smoking death
from: lung cancer for males is 66 and the deaths con-
stitute 0.006rc per year of the exposed populationt The
first 0i0069c of male smokers have died of lung cancer~
bv age 46 at which age the lung cancer death rate is
doubling evera four years. At~ age 66 the smoker lung
cancer death rate is doubling about every 13 years. In
other words. in passive smoking deaths we are dealing
with only the very most susceptible people, whereas in
direct smoking most of the victims are much, nearer
average susceptibility. Similar considerations apply to
the other diseases here discussed.
A qNestion often, raised, is that direcn smokers are
also passive smokers. so why do theynot get the passive
smoking related cancers. We have already pointedioutt that the use of nonexposed never smokers as
the re-
ferrent, category for smoker relative risk would increase
the apparent risk for smokers. Another possible expla-
nation is the probability of competing risks. Most of the
highly susceptible direct smokers would have died in
their forties or fifties from smoking related disease and
would not be available to die of.passive smoking relatedl
disease initheir sixties or, seventies.
The passive smoking mortality calculated in this
study. namely.46:000. mav be lbw: Repace and1owrey
(1985) calculate lung cancer deaths from pa$sive smok-
ing at, 4.665: or about 50% higher than our estimate..
primarily because of'postulated intense exposure atthe
workplace: a factor not taken into account in this study
since the relative risks are based largely on home ex-
posure. If Repace and Lowrey are eorrect, the higher
exposure would lead to corresponding increases in
deaths from heart'disease and other cancer. Also, only
ischemic heart disease is consid'ered' here. As the all
cause data in Appendix B indicate, other cardiovascular
diseases and diabetes may be sensitive toanvironmental
tobacco smoke and may increase the total deaths.
The new epidemiological studies on passive smoking
support the earlier ones and indicate that not only lung
cancer. but other cancer and heart disease are serious
problems. In fact, lung cancer appears to be only the
tip of the iceberg. To be on the safe side public health
policy should be to protect nonsmokers from environ-
mental tobacco smoke.
Arknowledgrmenrs - The author is grateful Ito Dr. T. Hiravama for
his data on mdi.idual cancerisites and for the detailf of his "all cause"
daaa. to R W. Wilson of the U.S. National Center for Health Statistics
for, data on the smoking status of U.S. residents bv 5 year age inter-
% afs. to L. Garfinkellfor the person years in his 1981 study- to J. M.
Samet fon data on male lung cancer in the New Mexico studc: to R.
C. Brownson for male lung cancer data in the Colorado study,:,to P.
Buffler for hen33- year.data, to StrJohn Crofton for,abstracu of
Lam er at. (1987) and Geng rr a!. (1967). to P. Reynolds for the
numFerof cases in their studN on femalecancere the number of lung
cancer cases. and their qttalitative results on mates. to D. P.' Sandler
fornonsmoker data on breast cancer. and toS. C. Hunt for enough
data from Manin er al: (1986a) to calculate an a11-exposure relative
risk, confidence limits and a weighting factor. The author also wishes
to thank James Robins. N. A.Dalager. Ji M Samet. VV.JL Blot. L.
C. Koo. A. H Wu. G. Pershagen. D. P. Sandler. D. Trichopoulbs
and J. L. Repace for helpful correspondence and'~discussion.
257
References
Akiba. S.. Kato. H.. and Blot. 1A' J(19k6) Passi%e smoking and
lung wncer, among Japanese women Cancer Res 46. SMU4-i807.
Alben. R. D.. Vanderlaan. M.. Burns. F.. andititshazumt. !s1, 11977)
Cancer Res 37. 223'-2.^35.
Balin. B. J. Broadwell. R. D.. Salcman. M.. EI-Kalhng. M (1996)
Avenues for entry of, penpheralh administered protein to the
central nervous system in mouse. rat. and squirrel monke). J.'
Camp Neurol 251. 26U-38p
Bcnditt. E. P. and$endttt. 1. M(1973) Evidence for a monoelonal'
ongin,of human atherosclerotic plaques. Proc N'trrl'Arad Sci 70.
1753-175ti.
Black: A. and Pntchard. J. N. (1984) A companson:of the regional
deposition and short termiclearance of tar particulate material
from cigarette smoke. wtthithae of 2:5 ,µm polyst.rene mtcro-
spheres. Aerosol Sci 15. 22;'-227.
BIbP. W. J. and Fraumeni. J. F. (1986) Passive smoking and lung
cancer. J Nar Cancer lnsr 77: 993-100(/:
Brownson. R. C.. Reif. JL S.. Keefe. T. J.. Ferguson. S K:. and
Pntzl! J.,A. (19871 Risk factors for adenocarnnoma of the lung.
Am J Epidemio! 175.,25-34.
Brututcmann. K. D.. Adams. J. D.. Ho: D. P S,. and Hoffmanm.
D (1978) Theinfiuencesoftobaccosmokeon indoor atmospheres
11. Volatile and tobacco specific nttrosamtnes m mam and sede
stream smoke and their contribution to mdoor polluuon. in Pro-
eecdings.4th Joint Conference on Sensrn¢ o( Ent)ronmenral
Pofluranu. New Orleans. Louisiana, 1977. American Chemical
Societ}. Washington. D.C.. 876-880.
B'uffier. P. A.. Pickle. L. W.. Mason, T. J.. and Contant. C. (,198..t)
The causes of lung cancer in Texas. in Lung cancer: Causes and
preveruion., M. Mizell and P. Correa. eds.. pp. 83-99. Verlag
Chemic International. New York.
Chan. W. C.. Colbourne. M. J.. Fune. S. C.. and~Ho. H. C. (1979)
Bronchial cancer in Hong Kong 1976-1977. B. J Cancer 39. 182-
192. Chan. W. C. and Fung. S. C. (1982) Lunc cancer in non-
smokers in Hong Kong. in Cancer campargn. Vol 6. CancerEp-
ulemrolbgr_ E. Grund'mann. cd'.. pp. 199-20'. Gustav Fischer
Vertag. Stungart. New York.
Correa. P.. Pickle. L. W.. Fonahan. E..,Lin. Y.. and Haenszel. 1ti':
(1983( Passive smoking and lung cancer. Lancet ii. 595-597.
Dalager. N'. A.. Pickle. L, W:. Mason. T. J.. Correa. P.. Fontham.
E.. Sternhagen. A.. er a!. (1986) The relation of passi.e smoking
to lung cancer. Cancer Res 46. SR(18-4R11 .
Fong. P. (196?) The hazard of'cigarette smoke to nonsmokers. J.
Bioi: Phts L0.,65-73:,
Freidman. G. D.. Pentti. D. B.. andBawol. R'. D. (1983) Prevalenee
and correlates of~passive smoking. Am J Public Health 73. 301-
4p5.
Fuchs. N. A. (1964) The Mechanics o/Aerosols. pp. 46-49. Mac-
millan. New York.
Garfinkel! L. (1981) Time trends in lung cancer mortality among
nonsmokers and a note on passi.c smoking. J A'or Cancrrlnsr66.
1061-1066.
Garfinkel. L.. Auerbach. o;. and~Jouben. L. (1985). fn>.olirntan
smoking and tung cancer: A case control stud5. J,1.'ar Cancer Inst
75, 463-itS9:.
Garland. C.. BanettConnor. E.. Suarez. L.. Criqui. M. H.. and
Wingard. D. L. (1985) Effects oL passive smoking on ischemc
hean disease tnonality of nonsmokers. Am J Eprdsmeol 121. (.45-
650.
Geng.,G. Y.. Liang. Z. H.. Zhang. A. 1'.. and Wu. G. L. (1987.
November) On the relationship between.ngarette smoking and
female lung cancer. Paper presented'at the 6th Wor(d Conference
on Smoking and Health. TokvoGernty. T. R.. Lee. P. S.. Hass. F. J.. Mannelli. A.. Wernen P.. and~
L.ourertto. R. V. (1979) Calculated depositton of tnhaled particles
in the airway generations of normalisublects, I Appl'Phrs,ol:
Rcsprrar Envrron Exercise Phvsiol'47. 867-873:.
Gillis. C. R.. Hole. D. J.. Hawthorne. V M.. and Bo% ie. P(198a)
The effect of emtronmental'tobacco smoke tn, two urban com,
munities in the west of Scotland.,EurJ'Rrsp Du 65. (supplement.
No. 133). 12J-126,
Hammond. C. (1966) Smoking in relation to the death rates of one
million men and women. in, Epidemrologual'Approaches to rhr,
Study of Cancer and Other Chronic Dtseasrs. 11' Haenszel. ed'..
pp. 127-204. U.S. Public Health Senace. Bethesda. MD', (ha-
tional Cancer Insntute Monograph l9).

ta
258
Helstng. K.1'.. Sandler. D! P.. Comstoek, G: W.. and Chee. E. (1988)
Heart disease mortality in nonsmokers iiving with smokers, Am
J Epidrmto! 127. 915-9:,2.
Heydcr. J. (;1984); Studies of particle deposition and clearance in
humans. in Probinns oJlnhalarorn Toirnn Studies P.' Grosdanoff',
er al:, eds.. pp. 155-180:,MMV-Medizm-Verlag. Munich.
Hiller. F. C.. MeCusker, K. T.. M'azumder.14. M. K.. W'ilson.l. D..
and Bone. Rl C 1198'_1 Deposition of stdestream dagarette smoke
in the human respiratory tract. Am Rcv Resp Dis 1ZS. 406-408.
Hirayama. T. (198aa)'Cancer mortality in nonsmoking women with
smoktn¢ husbands based on a large-scale cohort study in Japan.
Prev Sti<cd 13. 68(1-690 :
Hiravama. T. (1984b) Lung cancer in Japan: Effects of nutrition and
passive smoking.,in Lung cancer: Causes and prnenrion: M. Miz-
cil. P. Correa. eds.. pp. 175-195'. Vtrlag Chemie Intemational,
New York.
Hirayama. T. 11987) Passive smoking and cancer: An epidemiological
review: in Ganm. Monograph on Cancer Research' 33. Japan Sei:
entific Societies Press. Tokyo. pp. 127-135.
Humble. C. G.. Samet. J. M.. and Pathak. D. R. (1987) Marria¢e
to a smoker, and lung cancer risk. Am! Pub Heallh' 77, 598-602.
Inoue,:R. and Hirayama. T. (1987. November) Passive smoking and'
lune cancer in women: Paper presented'at the 6th World Con-
ferenee on,Smokmg and HealthTokyo.
Kabat. G. C. and Wvnder. E. L. (1984) Lung cancer in nonsmokers.
Cancer 53: 1214-1221.
Kabat.,G. C.. Diech. G. S,_ and~Wynder. E. L. (1986) Bladder cancer
in nonsmokers. Cancer 57. 36?-367.
Kalandtdi. A.. Tnchopoulbs, D.. Hatzakis. A.. Tzannes. S.- and
Saracci. R. (1987) Passive smoking and chronic obstructive lung
disease.. L'ancer u. 1325-1326.,
Knoth. A.. Bohn. H.. and Schmidt, F. (1983) Passivrauchcn ala Lun,
genkrebs-Utsache bei Nichtrauchennnen..Wedianrschc Klinik 79.
66-69:
Koo. L.,C:. Ho. J. H. C.. Saw. D.. and Ho. C. (1987) Measurements
of,passive smoking and estimates of litntt cancer, risk among non-
smoking Chinese fbmales. InrJ'Cancer39. 162-169:
Lam. T. H.. Kung, 1. T. M.. Wong: C. M.. Lam: W. K.. Kleevens,
1'. W, L., Saw. D:. rr al: (1987) Smoking, passive smoking and
histoio¢ical types in lung cancer in Hong Kong Chinese women.
Br J Cancer 56: 673-678:
Lam. W: K. ('1985) A clinicaf and epidemiolbttical study of carcinoma
of lungcancer in Hong Kong. M:D. thesis. University of Hong
Kong. Hon¢ Kong.,
Lee.:P. V.. Chamberlain. J.. and Alderson.M. R. O9861;Relationship
of passive smoking to risk of lung cancer and other smoking-
associated diseases. Br J Cancer 54. 97-105.
Martin. M. J.. Hunt. S. C.. and Williams. R., R. (19g6a, October).
Increased incidence of heart'attacks in nonsmoking women mar-
ned to smokers. Paper presented at annual meeting of Amencan,
Public Health Association.
kfartin. Nf. J..,Svendsen. K. H., and Kuller. L. H. (1986b. March)
Nonsmoking men marned to smokers are similar to nonsmoking
men married to nonsmokers.,Paper presented at the 7th Annual
Meetin¢: Society for Behavioral Medicine.
!vtelandn.,C:. Tarroni. G:. Prodi. V.. DcZaiacomo. T.. Formignani.
M.. and Lombardii C. C. (1983) Deposition of charged particles
in the human airways. J Aerosol Sci 14. 657-669.
Nfiller. G.H. (198a)iCancer. passive smoking and non-employed and
employed wives. WesrJMtd 140. 632-635.
Mitchell: R., 1. (1962) Controlled' measurement of smoke particle
retentioniin the respiratory tract. Am Rev Respir Der86, 526-
533.
.>,. Jl Wells
NationallCenter for Health Statistics f1986)', Health United States
1986: U.S. Dept. of Health and! Human Services. Public Health
Service. Hyattsville. MD. 106-109,
National Research Council (1986) Environmental tobacco smoke.
measuring exposures and assessing health effects. National Acad,
emy Press. Washington. D.C.
Office of Technology Assessment (1985) Smoking related deaths and
financial costs. Office ofTeehnologc Assessment.L'.S. Congress.,
Washington: D.C. Office on Smokm¢ and Health (d979-851 Bib-
liographv on smoking and health. U.S: Public Healttii Service.
Rockville. MD. and Smoking and Health Bulletins after 1985.
Penn. A.. Batastiiti', G.. Solomon. J.. Burns. F.. and Albert. R. E.
(1981) Cancer Res 41. 588-592.
Penn. A.. Garte. S. J.. Warren. L.. Nesta. D.. and Mindich. B. (1986)
Transforming gene in,human atherosclerotic plaque DNA. Proc
N'ar Acad Sci $3. 7951-7955.
Ptrshagen. G.. Hrubec. Z.. and Svensson, C. (,1987)',Passii+e smoking
and lung cancer in Swedish women. Am J Epidemiol,125., 17-2a..
Repace, 1. L. and Lowrey. A. H. (1985) A qµantrtative estimate of
nonsmokers' lung cancer risk from passive smoking. Environ lhr
11. 3-2-1:
Reynolds. P.. Kaplan. G. A.. and Cohen. R. D (1987. June):Passive
smoking and cancer, ineidence: prospective evidence from the Ala
meda County study. Paper presented at the Society for Epde
miologtc Research. Amherst. Massachusetts..
Rothman: K. J_ and Boice. J. D: (1982) Eprdenuologac Analvsu with
a,Progr'ammablt Calcularor, pp. 5-17. Epidemrology Resources,
Chesnut Hill. Massachusetts.
Rothman. K. J. (1986) Modern Epidemrology: pp. 139-1)37,
184-190. Little. Brown. Boston.
Russell. M. A. H.. Jarvis. yl. J.. and West. R. J. (1986)4;se of
urinary nicotine concentrations to estimate exposure and mortality
from passive smoking in non-smokers. Br J Addicnon 81. 317-
323.
Sandler. D. P.. Everson. R. B.- and Wilcox. A. J. (d985) Passive
smoking in adulthood and cancer risk. Am J Epiderniol'121. 37-
48.
Sandler. D. P.. Everson. R. B'.. and Wilcox. A. J. (;1986);Ci¢arette
smoking and breast cancer. Am J Epideamiol 123. 370-371.
Stober. W. O984);Lung dtmamicaand uptake of smoke constituents
by nonsmokers-a survey. Prev Med 13. 589-601.
Svendsen, K. H.. Kuller. L. H.. and Neaton. J. D. (1987) Effects of
passive smoking in the multiple risk factor intervention tnal: Am
J Epidemiol 11r6. 783-795.
Trichopoulos. D.. Kalandidi. A.. and Sparros, L. ('1983) Lung cancer
and passive smoking:,Conchttion of the Greek study. Lancer ii.
67'7-678.
U:S. Surgeon General (1986) The health consequences of in-
voluntary smoking, a report of the Surgeon General. DHHS
(CDC): 87-8398. U:S. Public Health Service. Rockville. Mary
land.
Vandenbroucke J. P.. Verheesen. J. H~ H., deBruin: A.. Mau-
ritz. B. J.. Vanider HeideWessel. C., and Van dcr Heide. R. %f.
(1984) Active and passive smoking in married couples: Results of
25 year follow up. Br .Ned l 288.,1801-1802.
Waldi N. J!. Nanchanal. K.. Thompson: S:, G.. and Cuckle. H. S.
(Q986) Does breathing other people's tobacco smoke cause lung
cancer' Br Med J 293. 1217-1222.
Wtlls, A. L(1986) Misclassification as a factor, in passive smoking
risk. Lancer u. 638;.
Wu.,A. H.. Henderson. B. E..:Pike. M. C.. and Yu. M C. (19851~
Smoking and other, nsk factors for lung cancer in womcn.J'Nai
Cancer Inst 74, 747-751. ~;
iP'

Adult mortalitv from passive smoking
259
Table A]. Annual U.S. male lung cancer deaths from passive smoking
Rtlative Rtsk ,
Constant at '_.1
Age of
Death Neversmoker
Death'i Rate
per 100.000 ~ Nonsmoker
Population
1000's
Fraction
Exposed Exposed
Populatton
1000's
Excess
Death Rate
Deaths
35-39 1.8 ~ 5156 0.71 3815 1.09 42
40~-44, 2.9 ' 4136 0.72 2980 1.78 53'
45-49 4.5 3477 0.70 2440 2.80 68
iI
50-54,
7.01
3431i
0.66
2260
4.46
101
55-59 11 3423 0.63' 2155 7.15 154
60-63 16, 3489 0.59 2054 10.7 219
65-69 23 3150 0.54 1695 15.9 269
70r74 33 2443 0.45 1099 24.3 _'67'
75-79' 49 1712 0.3' 633, 38.3 24_°'
80i84 72 921, . 0.27 249' 61.1 15''
85 - 95 516 0.08 41 96.0 39
Totals 15.9 31844 0.61 19420 8.26 1606
Appendix A
Derails of death calculations
Tables Al and A2 show the details of the death calculations
for male lung cancer and female cancer other, than lung and
are similar in all respects to Table 6 in the text except thart
no d'eelining relative risk calculation is shown for male lung
cancer since the evidence that was available (Hiravama.
1984a) indicated no suchAecline.
In Table A3 the details are given for the development ofi
the never smoker relative nsks for heart disease that were
use&in the death ~ calculations. As noted in the text. the 1963'
neversmoker heaR' death rates by 5-year intervals were ob-
tained~bv dividing the never smoker coronary heart deaths in
HammondTs (1966) appendix. Table 14, by the person years
in his appendix tables 2a and2b. Reduction factors to account for the change in heart death rates
between 1963 (end ofHammond7s study) and 1984 were then developed by 10:year
age intervals from the age specific heart death rates in table
24 ofiHealth U.S. 1986(NCHS.1986): These reduction factors
were modified for the fractions thought to be due to smoking
which were taken from~a staff report of the Office of Tech-
nology Assessment (OTA. 1985) to yield a combine&never
smoker reduction factor. interpolated back to 5-vear age in-
tervals. for application to the Hammond never smoker death
rates. These modified rates. which are forenrollment age and
therefore about 2 vearsyounger than age of death. were then,
plotted~ agairut age of death on semi.loe graphipaper. Treli
lines were then drawn through the female and the male points
to yield the values in the last column of Table A3.
Tables A4 and A5 are simply the details of the heart death
calculations as in Tables 6. Ali. and'A2'for cancer.
The deaths shown in Table 7 resulting from the corrections
for misclassification were calculated from the relative risks in
lines 4 of Table 5 taken as constant over the age ranee. The
modification of the observed relative risks for smoker mis-
classification as shown in Table 5 are based on misclassified
smoker relative risks calculated as follows. Based on as vet
unpublished work of Wells on misclassification it was assumed
that self-reported current smoker relative risks for male and
female lung cancer in the U.S. and U.K. were 11 and 7. and
4'.6 and 2.7 for male and female current smokers in Japan
Table A2. Annual U.S. female deaths from cancer other than lung from passive smoking.
Exposed Relative Risk
Constant ati 1.16 Relative
Risk
f Neversmoker
D
R Population
T
bl
6
E Declining
Age o
Death eath
ate
per 100.000 a
e
)
(
1000's. xcess
Death Rate
Deaths
RR Deaths
35-39 28 5781 3.9 22.5 4.5 13211 \V
40-44 48 . 425'- 6.7 285 29 14'11 ©
45-49 80 3423 11!.2 383 2 0 1--t9 ~
50-54 125 3355 17.6 589 1.56' 1579
55-59 190 3495 26.8 937 1.30 1591
60-64
265
32-18
37.7
1219
1.18 1352 V1
65-69 355' 2912 5711 1487 1.12 11" ~
70-74: 470 2030 68.7 1395 1.08 729
75-79 600 1472 89 0 1310 1.05 4'?1 ~
80-a4 750 547 114.7 627 1.034 138 ~
8-S* 900 100 14117 142 1.0:21 20
~
Totals 256 30595 28.1 8599 11165 '

260
A 1 %Le11s
Table A3. Development of 1984 neversmoker, heart death rates versus age.
Death rates from
Hammond (1966)
Age at enrolltd age
Range per100.000,
Females:.
1984
1984 wNeversmoker
Decline. Fraction Neversmoker Hammond's heart
in heart of,deciine Death Rate N.S. D.R. death rate
DR's 11 due to as x of1963 corrected by age of
1963-83 smoking (smoothed) for decline death
35-39 71 49 3.5 _'
0!
48 0 .
40-44 14.1 55 7.7 4.4
45-39' 20:.3 ' 60! 12.2 10.2
37 0
50-54 35:5 63 28.7 23
55-59 104 64 66 51
01
60-64 243 64 156 113
65-69 475 64 304 240
37 0
70-731 %f 64 615 480
75-79 1648 65 1072 870
35 0
80183 2774 70 1942 ' 1550
85+ - 21 0 79 - 2770
.Ncles
35-39
T
76
0
20
48 50.
40-44
79:5 77 61 36
45-49 85.5 78 67 68
42 50
50-54 220 77 169 128
55-59 397 75 298 237
37:5 ?5
60 -6s' 741 75 556 412
65-69 1089 76 827 730
32' 25
70-74 1936 76 1472 1150
75-79 2639 77 2021 1850'
25' 10
80-84 a'373'. 81 3343 2950
85+ - 1.4 10. 86 - 3700
(Hi'rayama. 1984a): The 5% of ever smokers who were as-
sumed miscliissified as never smokers were assumedito consist
of 239e light current smokers and 77% long term exsmokers.
The excess risks for currenr, self.reported smokers were re-
duced by 2/3 to yield~ relative risks for misclassified current
smokers an& by 11/12' for relative risks of misclassified
exsmokers essentially as was done by Wald er al: (1986). This
resulted in misclassified ever smoker relative risks of 2.4. and'
1.85 for males and4emales in the U.S. and U.K. and 1.5 and
1.25 for Japan. Worldwide misclassified smoker relative risks
were then calculated to be 1.8 for males and 1.6 for femalesbased on the proportion of "western" and
"eastern" cases.
The false relative risks shown on lines 2 in Table 5 were then
calculated using the formulae in Welis' unpublished work.
For female cancer other than lung. the smoker relative risk
of 1.05 was taken from Hammond (11966) and used as is since
the effect is too small to make any difference. For ischemic
hearr disease the ever smoker relative risks from Hammond'
Table A4. Annual'U. S. female heart deaths from passive smoking.
Relative Risk Relative
Neversmoker Exposed Constant at 1'.23 Risk
Death Rate Population Declining
Age of per 100:000 (Table 6) Excess
Death (Table A3) 1000's D.R. Deaths RR Deaths
35-39 2.0 5781 0.38 22 4.0 91
i0ii.t 4.4 4252 0.84 36 2.0 97' ~
45-49'
50-51 10.0
23 3423
3355 1.91
4.4 65
148 1.32
1.17 85
114
~
55-59' 51 3495 9.8 3" 1.17 :65'
~
60-64 1,13 3238' _2.1 713 1.17 548 .
.~
65-69
70-7.1 240
480 2912
2030 17.7,
97? 1385
1973 1.17
1.17 1062
1505
IiA
75-79 870 1472 180 2647 1.17 2010
80- 8a 1550 517. 33+t 1828 11.17 1374 ' ~
85+ 2700 100 607 607 1.17 J51
~
Totals 291 30595 31.9' 9768' 7602

Adult mortality from passive smoking
Table A5: Annual l' S. male heart deaths from passive smoking
Neversmoker
D
R
Exposed
P Relative Risk
Constant at 1.31 Relative
Risk
f
A eath
ate
000
100 opulation
(Tabl
A1)
E Declining
ge o
Death per
.
(Table A3) e
,
T000's xcess
D.R.
Deaths
RR
Deaths
35-39 20 3815 4.9 187 5.2 780
40-44 36 2980 8.9 265 3.0 879
45-49 68 2440 16.9 41!1 1'.9'- 929
50-54 128 2660 32.11 723' 1.42 951
55-59 237 2155 59.8 1289 1.28 1_'01'.
60-64 412 2051 105 2157 1.28 2009
65-69 730 1695 189 3195 1.28 297.
70-74: 1]50 1099 304 3341 1.28 3103
75-79 1850 633 500 3162 1.28 2933
80-84 2950 249 819 2039' 1.28 1887
85. 4700, 31 1377 565 520
Totals 521 19420 89'3 17335 181t.s
(1966) were taken as 2.3 for, males and 2.0 for females.. The
excess risks were reduced by 2/3 to vield relative risks for
misclassified ever smokers of approximately 1.4 for males and
1.3 for females. These were used worldwide with V4'ells' un-
published formulae to calculate the false heart disease relative
risks shown on lines : of Table 5.
Appendix B
Relatrt.e risks for all'causes of death, and for
emphrsema and chronic obstructive lung disease
Data relating all causes of death with passive smoking for:
females have been reported for four prospective studies to
talltng 9537 cases as shown in Table B 1. The combined relative
risk is 1.165 with 95% confidence limits of 1.11 to 1.22. The
onlv male data available are 75 cases from Gillis et aL (1984))
with a relative risk offl 1.0 so no male analysis was made.
The calculation of the total number of female deaths from
all causes for passive smoking is shown in Table B2. The total.,
3a.1641. is considerably larger than the total for cancer plus
hean of 19.359 shown in Table 7. Some of the difference is
due to uncenainties in the ealculations, but other causes of
261
death that might contribute to the all cause total. based on
data in a pnvate communication from Dr. Htravama. are
cerebrovascular disease, other hean disease. diabetes. and
ulixr.
Hirayama (private communication. also reported preli-
minarilv at 5th World Conference on SmokinQ and Health.
Winnipeg. 1983)provides data relating deaths from emph.-
sema with passive smoking in womem Hisrelativr risk. based
on 106 cases is 1.3 with 95rir confidence limits of 0:85 to'_.05.
Kalandidi'et a!_ (1987) report incidence data for chronic ob
structive lung disease based on 103 cases with an adjusted
relative risk of about 1.4. Lee er aC (',19861 report incidence
data for chronic bronchitis from spouse exposure Based~on
17 cases the adjusted relative risk is 1.22. A,wetehted a%eraee
of these three relative risks would be about 1.3i. The only
neversmoker death rate we have is from Hammond (1966)
for emphysema at 2 x 10-`. Assuming 76 r exposure. the
excess death rate for passive smoking using Eq. (2) would be
0:55 x 10'5 and the total deaths for an.exposed population
of 30.61million would~ be about' 170. Even, if this number iss
doubled to take into account deaths from formsof chronic
far
obstructive lung disease other than emphysema. it u stillT
below the total for cancer and ischemic heart dtsease.
Table BL. Female relative risks for all causes of death from passive smoking.
l All
Exposures Mantel
Trend
Locale Tota
Cases RR 95% C.L. 1tail p
Cohort Studies:
Hiravama (1987)
Japan
9106
1.17
1.12=1.23'
0:(ItKK)1i
Gillis a at.' (198t), Scotland 102 1.45 0.91-2.30
Garland et a!. (1985) California 79 1.06 0.65-1.73'
Vandenbroucke et at. (1983)" Holland 250 0.79 0.57-1.09'
Combined Chon: 9537 1.165
'Dr. Hiravama (private communication):provided the data necessary to calculate these items.,
'Data from 25 vear follow up: Relative risk wasA!89 (0.50-1.62)ifor 1,5 vear follow up. This stud%
is weak
in,that exsmokmg women,were tncluded among the "nonsmokers." and nonsmoking women,exposed to
exsmoker husbands were included in the "nonexposed " The weakness of the study, is emphasized in
that
the smoking women had a lower overall death rate (33.a'~/rYthan thc nonexposed nonsmokers (38, l1:
)_

262
ge
Range Nevetsmoker
Death Rates
(rom Hammond
(19661 at
enrolled age
per T00.000
35-39 136
.t0-4t 178
45-49 254
50-54 352
55-59 561
60-64 867,
65-69 1492
70+-74 2585
75-79 4790
80-8s 8J08
85+ -
A. J Wells
Table B_. Annual US. female deaths from all causes from passive smoking.
Decrement
due to heart
death rate
1963-84
per 100.000
Corrected
Neversrnoker
death rate at
enrolled age
per 100.000
3.6 132.4
6.4 17;1'.6
8.2 245,8
16.8 335:.'
38 523
87 780
171 13211
346 2239
576 4214
832 7576
-- -
Totals
Deaths per million total population
Lee er al: (1986) report data on chronic bronchitis life long
nonsmoking in males exposed,to a smoking spouse. Based on
nine cases the ad)usted relative risk was 0.34. However. for
general' exposure (a' cases) a positive relative risk was ob-
served. No analysis of these data was attempted.
heversmoker:
death rate
t
d
P
l9
io
F Relative Risk
Constant at.1.165
correc
e
to age of death
per 100.000 opu
t
n
exposed
1000's raction
of population
exposed
Excess
D R.
Deaths
120 5781 0,94 17.1 991
155 J'-s, 0.92 21.2 9a-t
212 3323 0;89' 30.5' Ioi-t
300 3355 0.87 43.3 la5'_
445 3495 0.81 6-t15 _254
675 3228 077 98':8 31901
1070 2912 0.70 1583, .1609
1830 2030 0.59 275.2 5596
3250 1472' 0:49' 496.1 7303
6000 547 0:29' 9-t-t.8 5168
10!000' 100 0.10 1623 1623
30595 1]1 7 31]6-t
143
Appendix C
Rate difference mode!'for assessing female ischemic
hearr deaths from passive smoking
A rate difference or absolute risk model was investigated
for female ischemic heart disease in order to compare it to
the relative risk models in ability to translate experience from
one type of culture to another. Female ischemic heart disease
was chosen because considerable data exist and because heart
disease is the largest contributor to total deaths. Also. the
relative risk model seems already to be welCestablished for
lung cancer (Wald ct al:. 1986; Blot and Fraumeni. 1986) so
a comparison~in another disease category appeared to be ap-
propriate.
Data from the four: cohort studies (see Table 4) were com-
bined using the direct pooling equations described on page
183 in Rothman (1986). The two case/control studies were
omitted. Although their combined rate difference was essen-
tially the same as that for the cohort studies, no good way
could be found ao combine it with that from the cohort studies.
Death rates for exposed and not exposed populations were
obtained by dividing the observed deaths in each category by
person years which were equated to the mid-point populations
multiplied'bythe years offoll'owup. The rate difference was
then obtained by subtracting the nonexposed death rate from
the exposed death rate. Vanances and weights were calculated
by Rothman's formulae., The combined rate difference was
obtained by summing the weighted rate differences and di-
viding by the sum of the weights. Confidence limits (95%):
were equated',to the rate difference =1.96 (variance)°=.
The results of these calculations are summarizcd'in Table
Cl. The cohort data were also combined using Program 7 of
Rothman and Boice (1982) ,', with results essentiallv,idemical
to those shown in Table C1 for direct pooling. The relative
heterogeneity of the relative nsks ('RR) vs.,the rate differences
(RD) can be approximated; by considering the range of RR-
1 versus the range of RD: The range of RR-1 is from 0;16 to
2.6 for a factor of. 163. The range of~ the rate differences is
3.7 to 262 'or a factor of 71. The ratio for the two large studies,
Helsingeral: (1988) land Hiravama (1984b), for RR-I': is 0:2d"
0.16 = 1.5 and for RD is 20.7/3.7 = 5.6. The 95"c confidence
limits for the rate ratio combination is tighter than for the
rate difference combination_ ,#lso, the Hiravama study dom-
inates the rate difference aggregation muchlmore than inithe
rate ratio aggregation. providing 64% of the combined weight
(last column of Table Cl) in the rate difference case vs. only
17 0 of the combined weight in the rate ratio case.
Table C1. Rate difference c alculations for fe male i schemic heart disease.
T Relative Risk
from Table 3. Rate difference
x 10''
Wn¢hts
fo
RD ~
RD x ~
h
otal
Cases
RR
95% C.L.
RD
95Pr C.L. r
x 10-" weig
t
x 10- yN~'
Cohort Studies:
Hirayama (d98sb)
394
1.16
0.9- 1.4
3.7
-2.1- 9.6
11110
41 a
Gillis er al. (19fi3) : 21 3.6 0.9-13'.8 169.1 30.7-307.6 2 31
Garlan&er al. (1985) 19 3.5 0;9-13,6 262.2 36.0-188.4 0 & 2.0
Hetsin¢ n a!: (19681 988 1.25' 1.1- 1.4 :0:7 -0.2- 41.6 88 IR.2
Combined Cohort 1522' 1.23 1.1- l.l 5 1 -0:2- 11.1 1201 65 0
~

Adult mortality from passive smoking
Table D1. Regionaliparticle deposition from mouth breathing of side stream smoke
Fraction of inhaled
Aero- Relative particle mass deposued`
dvrta
i V
l M
m
c
diameter
Cube of
Relative o
ume
(Weight) ass
Distribution
mouth trachro
µm diameter eonantration' per 0.liam , 'ii throat, bronchial alveolar
263
F1ass
deposited as
r~ of totall
mass inhaled'
0.20 .008'. 1.5 0.006 0.3 0 0 0.13 0.0a
0.25 .016 6.5 0.051 2.4' 0 0 0.1?' 0:29
0.30 .0.7 10I0, 0.135 6A 0 0 0.115 0:74
0.35 .043 13:0 0:280 13.2 0 0 0.108 1 43
0 40 .064 13.01 0;i 16 19.6 0' 0 0.10 1.96
0.45 .091 6.5 0;296 14.0 0! 0 0.105 1.41
0.50 .125 3.5 032S 15.5 01 0 0.11 1.71
0.60 .216 1.25 0.270 12.7 0 0 0.115 1 .4b.
0.70 .343 0.5' 0.17~_ 8.1'. 0 0 0.12 0.97
0.80 .51L 0.25 0.128 6.0 0 0 0.13 0_78
0:90 .729 0.05 0.036 1.7 0 0 0.14 0.24
1.00 1.0 0 0 0 0 0 0.15 0(K)
:.1!18 99.9 11.08
From Hiller rr a!. (19821. Fig. 1.,
'From ~Hevder (1984).,Table 1. 250 cm'fsecond mean flo%% ' rate. 4 second breathing cvcle.
This domination of the rate difference model by the Jap
anese study is evident from some rouch death calculations.
Use of the combined rate difference (5;a x 10") with the
exposed female population from Table A4: (30.6 million))
yields total deaths of L6fi2 compared with 9.768 calculate&
from the constant rate ratio modell VJhen the rate differences
are plotted against age of death~and weighted accordinglv it
is found that the "westertr " rate differences increase sharply
with age whereas the Japanese rate difference stays constant
at about 4 x 10'. Constructing a weighted average of these
western-' and ' eastern" death rates for each of the 5 vear
age ranges and multiplying h} the corresponding exposed pop-
ulations yields a total of about 2.100 deaths compared with
7.602 in the second relative risk modell Use of the Japanese
data alone vield's about 1.200 deaths. Use of oniv the "west-
ern" data (Gillis er al.. 1994: ',Garland ei . al.. 1988: Helsing
ett al: ) at a constant, rate difference yields 7,950~deaths while
use of "western~' data with the rate difference vanine with
age yield5 about 30.000 deaths. Thus. the death caltulations
using rate differences are quite vofatile, Also. it is evidentt
that with the rate differences it is not feasible to carrn- over
the "eastern° experience. in ischemic hearr disease at
least, for use in a"western" setting.. Accordmglt. it' was
concluded that the absolute risk model' is not as suited to
combining risks for passive smoking asthe relative risk
models.
Table D3: Regional ~ particle deposition from nose breathing of sidestream smoke.
Aero-
i
Fraction of inhaled
particle mass deposited" Mass deposited as
K
of total mass
dynam
c Mass
diameter distribution
mouth
ttachco- inhaled
µm % . nose throat bronchiai alveolar nose alveolar
0:20 0:3 0 0 0 0.19 0.00 0.06
0125 2.4 0.005 0 0 0.172 0.01 0.41
030 6.4 0.01 0 0 0.155 0.06 0.99
0.35 13.2 0.015 0 0 0.13R 0.20 1.82
040 19.6 0.02 0 0 0.12 0.39 2.35
0.45 14.0 0.03' 0 0 0.11-2 0.42 1.70 ~
0.50 15.5 0.04 0 0 0.125 0.62 1.94
0.60 12.7 0.05 0 0 0.1_R 0;6,t 163
0.70 8.11 0.06 0 0 0.13 0.49 1 05
0
80 6
0 077
0 0 0 0:13; 0!46 (1!Rn',
L
.
0.90 .
1.7 .
0.093 0 0 0:137 0!16 0;23 #"
1.00 0.0 0.11 0 0 0:1a 0.(10 0,(uiI ~
3.45 1'_.99
°From Table D1!. ~
"From Hevden(1984). Table 2. 250 cm',second'mean.OoM rate. .4 secondbreathtng cycle..

264
A J MctIA
Table D3. Smoke Particle deposition patterns in direct and passive smoking
Direct Smokintt Passive Smoking Direm, Passisc
Entry site
Particulate inhaled per day. me. Mouth
:a0 tiose
2.8
86
Particle Size inhaled. µm 0 7 0.4
Particle size exhaled.,µm 07 04
Retained in nose, 5r 0 3.5
Retained in mouth. i7', 25 0
Retained in tracheerbronchial reaion. % 35 0
Retained in near alveolar reeion_ % 19 0
Retained in deep alveolarregion. 4c 9 13
Totallretained. °k 90 16.5
Particulate retained. total. mg. 192, 046 177
Particulate retained. alveolar. mg. 48 0.36 133
Particulate retained. deep alveolar. mg. 2-1 0.36 61
Appendix D
Dose considerarions
As noted in the text. there is a wide difference between
the observed'disease ratio between passive and active smokers
and the ratio of cigarette smoke particulate retained by, each.
Also, the cancer sites appear to differ. On the assumption
that part of these differences may be due to differences in
deposition sites between passive smoking and active smoking,
calculations were carried out to try to pinpoint these differ-
ences.
The calt:ulations for passive smoking are reasonably
straightforward. Stober (1984) has summarized all the uncer-
tainties in this type of calculation. Nevertheless, the best ap-
proa& appears to be to use the data of Hiller et al. (1982)
for the particle size range of side stream smoke, centering
around 0:4 µm, and the mathematical lung modellof Heyder
(1983), for inert particles. Integration of these two data sets
yields a distribution of deposited weights by particle size for
mouth breathing (see Table D1) which. when summed: vields
exactlv the total': deposition observed by Hiller et al:. (1982)
indicating that the Heyder modeliholds for passive smoking.
The same inhaled particle size distribution camthenbe applied
to Hevder's nose breathing case (see Table D2) which yields
nasal deposition of 3.5c%e and deposition in the alveolar region
of the lUng of 13:04c. The model predicts zero deposition for
both the mouth,throat and the tracheo-bronchial regions.
From the depositiomcurves of Gerrity er aG (1979) (Fig. 2)
for iron oxide extrapolated to a particle size of 0.25 µm.(which
is eq uivalent to an aerodynamic diameter of 0.4 µm ) it appears
that all of the lung deposition from passive smoking probably
occurs deep in the alveolar region at generation 19 or beyond.
Black and Pritchard (1984) have determined the half-time for
alveolar retention for direct cigarette smoke to be 17 hours
indicating that the smoke particles dissolve and clear into the
blood or lymph system. There is every reason to believe that
the passive smoke particles clear the same way.
With direct smoking there has so far been no model de-
veloped'that explains the observed phenomena, namely that
the inhaled particle size is about 0.7' µm, that 70% to 809c
of the inhaled smoke is retained, that 15 to 359'e is retained
in the mouth, and that the exhaled~panicle size is also about
0.7 µm; The Heyder modeli at 0l7 µm, would predict total
retentiomof only 12%. To achieve 75% retention, the Heyder
model would require an effective particle size of 6.5 µm, Main
streamismoke is knowmto agglomerate. but if it agglomerated
to 6.5 µm, the exhaled' smoke. according to the He.der
modeli, would be about 6 µm, much too, large compared to
that observed. Mitchell (1962) observed that direct smoke
particles grow in the mouth to about 1.15~µmi and that the
smoke exhaled from the lung after a S second retention period
had a mass median diameter size of 0.65 µm. Let us assume
that the 0.65 µm part of'the smoke follows Hevder's model
an&thar209c of the total smoke inhaled was exhaled', all from
the 0;65 µm fraction. The inhaled part of the smoke corre-
sponding with the 0.65 µm part exhaled would have the same
particle size and would deposit about 12%. deep in the al-
veolar region.. This is 1'217c of 22.7ro of the total smoke in-
haled'~ or 2.7% of the total inhaled smoke. The balance of
the inhaled smoke (77%) would have a larger average particle
sizeabout 1.3 µm. Black and Pritchard (198-1)lfound. based
on clearance data, thatthe rates of alveolar c+eposition to
alveolar plus tracheo-bronchial deposition, in, direct smoking
is 0.36. Also, as noted, some amount, say 25% of the total
inlet smoke should deposit in the mouth and throat. all of
which would have to come from thislarger size fraction.,Sum-
marizing these numbers, of the 100 -'0 -'5 = 55cc of
total smoke particulate that reaches the lun¢ and is non ex-
haled, 0~64 x 55, = 35% deposits in the tracheobronchial
region and 0.3& x 55 = 20% deposits in the alveolar region,
We have already accounted for 3% of the alveolar deposition
from the 0:65 µm particles. The remaining 17% would come
from the largerparticles.,Based on the alveolar/tracheo-bron-
chial split and using the curves of Gerrity er al: (1979) it would
be expected that about 2/3 of the alveolar deposit or l1,rr,
would deposit in the "near° alveolar region, generations 16-
18, and 6% in the "deep" alveolar region., generations 19-
21, for a total "deep" alveolar deposition of 9%. These cal-
culations are summarized in Table D3.
Just what the mechanisms are for so much direct smoke
deposition remains unclear. Certainly impaction and sedi-
mentatiom(thc Heyder model) do not account for it. Stober
(196-t)isuggests that electricallcharges in the newly generated
smoke particles (see Melandri er al:, 1983) mav aceounv for
some of it. Another possible mechanism is the cloud settling
phenomenon as described by Fuchs(196J).
Whatever the mechanism, a reasonably clear idea of the
regionalI deposition patterns from direct and passive smoking

Adult mortalirkfnm passne smoking
can be obtained as shown in Table D3. The nasal deposition
from passive smoking could account for the observed nasal
sinus cancer. Also. if the observation of Balin er aL (1986) is
correct that there is a direct passage for toxics from the nose
to~ the brain, it could also account for the observed brainn
cancer. Ih the deep alveolar region the ratio of direet to pas-
:h`
sive deposition is much closer to the inhaled'ratio ~than to the
"total retained" ratio. It is from the deep alveolar region thac
the smoke particles are solubilized and clearedGnto the blbo&
and lymph systems possibly to cause cancers of the liver,
breast and endocrine glands, leukemia. hmphoma and ar-
terial plaques.
